Journal d'ophtalmologie clinique et expérimentale
Libre accès

Abstrait

Intravitreal Vascular Endothelium Growth Factor Inhibitors for Retinal Macroaneurysms

Carlos Menezes and Carla Teixeira

Last year our group published the case of a foveal longstanding retinal macroaneurysm successfully treated with intravitreal ranibizumab. A few previous and subsequent studies also reported the safety and effectiveness of intravitreal vascular endothelium growth factor inhibitors (anti-VEGF) in other more common cases of retinal macroaneurysms. In this commentary we proposed to make a brief review of this entity, particularly of its complications and its management with emphasis on anti-VEGF therapy